KFC
BSX icon

Klingenstein Fields & Co’s Boston Scientific BSX Stock Holding History

Klingenstein Fields & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
+175,672
New +$14.1M 0.43% 57

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Klingenstein Fields & Co's BSX Position: Q1 2026 in Review

Klingenstein Fields & Co opened a new position in Boston Scientific (BSX) in Q1 2026: 175,672 shares worth $11M. The stake represents 0.43% of the portfolio and ranks #57 among its holdings.

1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Klingenstein Fields & Co held 175,672 shares of Boston Scientific worth $11M as of Q1 2026.
  • Boston Scientific was a new Klingenstein Fields & Co position in Q1 2026.
  • Boston Scientific made up 0.43% of Klingenstein Fields & Co's portfolio in Q1 2026, its #57 holding.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.